1. Home
  2. BTMD

as of 12-01-2025 3:06pm EST

$2.59
$0.08
-3.00%
Stocks Health Care Medicinal Chemicals and Botanical Products Nasdaq

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.

Chart Type:
Time Range:
Founded: 2012 Country:
United States
United States
Employees: N/A City: IRVING
Market Cap: 90.6M IPO Year: N/A
Target Price: $6.00 AVG Volume (30 days): 142.6K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 0.78 EPS Growth: 270.48
52 Week Low/High: $2.31 - $6.98 Next Earning Date: 11-05-2025
Revenue: $195,645,000 Revenue Growth: 1.34%
Revenue Growth (this year): -0.34% Revenue Growth (next year): 4.85%

AI-Powered BTMD Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 67.35%
67.35%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: